Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication
Authors:
Open Access
- 4 April 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 15, 1305640
Abstract
Blood glycosylated hemoglobin level can be affected by various factors in patients with type 2 diabetes and cardiovascular diseases. Frequent measurements are expensive, and a suitable estimation method could improve treatment outcomes.Patients and methods: 93 patients were recruited in this research. We analyzed a number of parameters such as age, glucose level, blood pressure, Body Mass Index, cholesterol level, echocardiography et al. Patients were prescribed metformin. One group (n=60) additionally was taking sitagliptin. We applied eight machine learning methods (k nearest neighbors, Random Forest, Support Vector Machine, Extra Trees, XGBoost, Linear Regression including Lasso, and ElasticNet) to predict exact values of glycosylated hemoglobin in two years.Results: We applied a feature selection approach using step-by-step removal of them, Linear Regression on remaining features, and Pearson’s correlation coefficient on the validation set. As a result, we got four different subsets for each group. We compared all eight Machine Learning methods using different hyperparameters on validation sets and chose the best models. We tested the best models on the external testing set and got R2 = 0.88, C Index = 0.857, Accuracy = 0.846, and MAE (Mean Absolute Error) = 0.65 for the first group, R2 = 0.86, C Index = 0.80, Accuracy = 0.75, and MAE = 0.41 for the second group.Conclusion: The resulting algorithms could be used to assist clinical decision-making on prescribing anti-diabetic medications in pursuit of achieving glycemic control.Keywords
This publication has 14 references indexed in Scilit:
- Predicting three-month fasting blood glucose and glycated hemoglobin changes in patients with type 2 diabetes mellitus based on multiple machine learning algorithmsScientific Reports, 2023
- Implementation of five machine learning methods to predict the 52-week blood glucose level in patients with type 2 diabetesFrontiers in Endocrinology, 2023
- Status of glycosylated hemoglobin and prediction of glycemic control among patients with insulin-treated type 2 diabetes in North China: a multicenter observational studyChinese Medical Journal, 2019
- Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complicationsEuropean Journal of Preventive Cardiology, 2019
- Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitusBioscience Reports, 2019
- Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech RepublicDiabetes Therapy, 2018
- Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable anginaLipids in Health and Disease, 2014
- Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysisCurrent Medical Research and Opinion, 2013
- Glycosylated Hemoglobin in Relationship to Cardiovascular Outcomes and Death in Patients with Type 2 Diabetes: A Systematic Review and Meta-AnalysisPLOS ONE, 2012
- Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markersTranslational Research, 2012